These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37461740)

  • 1. SARS-CoV-2 Spike Protein Mutations in Different Variants: A Comparison Between Vaccinated and Unvaccinated Population in Western Amazonia.
    Sgorlon G; Roca TP; Passos-Silva AM; Custódio MGF; Queiroz JADS; da Silva ALF; Teixeira KS; Batista FS; Salcedo JMV; Rampazzo RCP; Naveca FG; Vieira D
    Bioinform Biol Insights; 2023; 17():11779322231186477. PubMed ID: 37461740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants associated with temporal succession of SARS-CoV-2 variants in Uttar Pradesh, India.
    Pal S; Mehta P; Pandey A; Ara A; Ghoshal U; Ghoshal UC; Pandey R; Tripathi RK; Yadav PN; Ravishankar R; Kundu TK; Rajender S
    Front Microbiol; 2023; 14():986729. PubMed ID: 36819024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SARS CoV-2 Omicron BA.1 and a novel Delta lineage by rapid methods and partial spike protein sequences in Sulaymaniyah Province, Iraq.
    Rasheed MK; Awrahman HA; Amin Al-Jaf SM; Niranji SS
    Immun Inflamm Dis; 2023 Mar; 11(3):e801. PubMed ID: 36988244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing.
    Bellocchi MC; Scutari R; Carioti L; Iannetta M; Marchegiani G; Piermatteo L; Coppola L; Tedde S; Duca L; Malagnino V; Ansaldo L; Braccialarghe N; D Anna S; Santoro MM; Di Lorenzo A; Salpini R; Teti E; Svicher V; Andreoni M; Sarmati L; Ceccherini-Silberstein F; On Behalf Of The Ptv-Utv-Id-Covid Group
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant.
    Bansal K; Kumar S
    Virus Res; 2022 Jul; 315():198765. PubMed ID: 35367284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of Omicron VOC and its rapid spread and persistence in the Western Amazon.
    Sgorlon G; Roca TP; Passos-Silva AM; Queiroz JAS; Teixeira KS; Araújo A; Batista FS; Souza VR; Oliveira FM; Morello LG; Marchini FK; Salcedo JMV; Rampazzo RCP; Naveca FG; Vieira D
    PLoS One; 2023; 18(8):e0285742. PubMed ID: 37590264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing.
    Mannsverk S; Bergholm J; Palanisamy N; Ellström P; Kaden R; Lindh J; Lennerstrand J
    Virol J; 2022 Oct; 19(1):164. PubMed ID: 36258215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
    Banerjee A; Lew J; Kroeker A; Baid K; Aftanas P; Nirmalarajah K; Maguire F; Kozak R; McDonald R; Lang A; Gerdts V; Straus SE; Gilbert L; Li AX; Mozafarihashjin M; Walmsley S; Gingras AC; Wrana JL; Mazzulli T; Colwill K; McGeer AJ; Mubareka S; Falzarano D
    Med; 2022 Jun; 3(6):422-432.e3. PubMed ID: 35437520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.
    Puhach O; Adea K; Hulo N; Sattonnet P; Genecand C; Iten A; Jacquérioz F; Kaiser L; Vetter P; Eckerle I; Meyer B
    Nat Med; 2022 Jul; 28(7):1491-1500. PubMed ID: 35395151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking SARS-CoV-2 variants through pandemic waves using RT-PCR testing in low-resource settings.
    Nasir A; Aamir UB; Kanji A; Bukhari AR; Ansar Z; Ghanchi NK; Masood KI; Samreen A; Islam N; Ghani S; Syed MA; Wassan M; Mahmood SF; Hasan Z
    PLOS Glob Public Health; 2023; 3(6):e0001896. PubMed ID: 37262051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covid-19 variants: Impact on transmissibility and virulence.
    Malik YA
    Malays J Pathol; 2022 Dec; 44(3):387-396. PubMed ID: 36591708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of SARS-CoV-2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays.
    Sit BHM; Po KHL; Cheung YY; Tsang AKL; Leung PKL; Zheng J; Lam AYT; Lam ETK; Ng KHL; Chan RCW
    J Clin Virol Plus; 2022 Aug; 2(3):100091. PubMed ID: 35761832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
    Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
    Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.